Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer

Figure 3

Differential MAL2 expressions in the boxplot. The expression of MAL2 is grouped by age (a), stage (b), T classification (c), N classification (d), M classification (e), vital status (f), ER status (g), PR status (h), and HER2 status (i).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)